Originally published In Press as doi:10.1074/jbc.M112470200 on February 22, 2002
J. Biol. Chem., Vol. 277, Issue 19, 16976-16984, May 10, 2002
A Mouse Serine Protease TESP5 Is Selectively Included into Lipid
Rafts of Sperm Membrane Presumably as a
Glycosylphosphatidylinositol-anchored Protein*
Arata
Honda,
Kazuo
Yamagata
,
Shin
Sugiura,
Katsuto
Watanabe, and
Tadashi
Baba§
From the Institute of Applied Biochemistry, University of Tsukuba,
Tsukuba Science City, Ibaraki 305-8572, Japan
Received for publication, December 31, 2001, and in revised form, February 20, 2002
 |
ABSTRACT |
We have previously indicated that at
least in mouse, sperm serine protease(s) other than acrosin probably
act on the limited proteolysis of egg zona pellucida to create a
penetration pathway for motile sperm, although the participation of
acrosin cannot be ruled out completely. A 42-kDa gelatin-hydrolyzing
serine protease present in mouse sperm is a candidate enzyme involved
in the sperm penetration of the zona pellucida. In this study, we have
PCR-amplified an EST clone encoding a testicular serine protease,
termed TESP5, and then screened a mouse genomic DNA library using the
DNA fragment as a probe. The DNA sequence of the isolated genomic
clones indicated that the TESP5 gene is identical to
the genes coding for testicular testisin and eosinophilic esp-1.
Immunochemical analysis using affinity-purified anti-TESP5 antibody
revealed that 42- and 41-kDa forms of TESP5 with the isoelectric points
of 5.0 to 5.5 are localized in the head, cytoplasmic droplet, and
midpiece of cauda epididymal sperm probably as a membranous protein.
Moreover, these two forms of TESP5 were selectively included into
Triton X-100-insoluble microdomains, lipid rafts, of the sperm
membranes. These results show the identity between TESP5/testisin/esp-1
and the 42-kDa sperm serine protease. When HEK293 cells were
transformed by an expression plasmid carrying the entire protein-coding
region of TESP5, the recombinant protein produced was released from the cell membrane by treatment with Bacillus cereus
phosphatidylinositol-specific phospholipase C, indicating that TESP5 is
glycosylphosphatidylinositol-anchored on the cell surface. Enzymatic
properties of recombinant TESP5 was similar to but distinguished from
those of rat acrosin and pancreatic trypsin by the substrate
specificity and inhibitory effects of serine protease inhibitors.
 |
INTRODUCTION |
Mammalian fertilization involves a complex set of molecular
events, including adhesion and binding of sperm to the zona
pellucida (ZP),1 an
extracellular glycoprotein matrix surrounding the egg, acrosome reaction, penetration of sperm through the ZP, and fusion between sperm
and egg (for reviews, see Refs. 1-4). Of these events, the acrosome
reaction is a fusion between the outer acrosomal and plasma membranes
at the anterior region of sperm head. Consequently, the acrosomal
components are released and interact with the ZP. The sperm penetration
of the ZP is believed to require both sperm motility and enzymatic
hydrolysis by acrosomal protease(s) (1, 5).
A sperm serine protease, acrosin, is localized in the acrosomal matrix
as an enzymatically inactive zymogen, proacrosin, which is then
converted into the active form during the acrosome reaction (6, 7). The
role of acrosin in fertilization has long been considered to
participate in the limited proteolysis of ZP, which enables sperm to
penetrate the ZP. However, our previous work (8) using
acrosin-deficient mutant mice conclusively showed that acrosin is not
essential both for the sperm penetration of the egg ZP and for
fertilization. The deficiency of acrosin causes a delay in the
dispersal of acrosomal proteins during the acrosome reaction (9), which
results in the delayed sperm penetration of the ZP at the early stages
of fertilization in vitro after insemination (8). It
has been reported that various trypsin inhibitors prevent sperm from
penetrating the ZP (10-14). Since p-aminobenzamidine (pAB),
a competitive inhibitor for trypsin-like serine proteases, effectively
blocks the penetration of acrosin-deficient mouse sperm through the ZP
(14), pAB-sensitive protease other than acrosin likely functions in the
penetration step of mouse sperm. We (8, 14, 15) have demonstrated that
two gelatin-hydrolyzing proteins with sizes of 42 and 41 kDa are
present in the extracts of wild-type mouse sperm, whereas
acrosin-deficient mouse sperm contain the 42-kDa protein and apparently
lack the 41-kDa protein. The inhibition profiles toward serine protease
inhibitors indicate that these two gelatin-hydrolyzing proteins belong
to the superfamily of trypsin-like serine proteases (14). Thus, the
42-kDa protease is a candidate enzyme involved in the sperm penetration
of egg ZP at least in mouse.
As described above, only a 42-kDa serine protease exhibiting
gelatin-hydrolyzing activity is found in sperm extracts from wild-type
and acrosin-deficient mice (8, 14, 15). Production of the active 42- and 41-kDa proteases is accelerated by incubation of the sperm extracts
at pH 8.5, and by addition of exogenous pancreatic trypsin to the
extracts. The gelatin-hydrolyzing activity of the 42-kDa protease in
the acrosin-deficient mouse remains constant during the pH 8.5 incubation (8, 14), and the active 41-kDa protease is not found in the
sperm extracts without addition of exogenous trypsin (15). These data
imply that the 42-kDa protease as well as acrosin may be present in
acrosome-intact sperm as an enzymatically inactive pro-protein
(zymogen), a part of which is already converted into the active enzyme
by a processing enzyme(s) with a trypsin-like cleavage specificity,
including acrosin, and/or by autoactivation (14, 15). It is also
possible that the zymogens of the 42- and 41-kDa proteases are
essentially different molecules, or that the 41-kDa protease is
produced from the 42-kDa protease by proteolytic processing. To prove
these possibilities, the molecular basis of the pro- and mature forms of the 42-kDa serine protease needs to be clarified.
cDNA clones encoding four different serine proteases, TESP1
(testicular serine protease 1),
TESP2, TESP3, and TESP4, have been identified as candidates for 42-kDa
gelatin-hydrolyzing enzyme in mouse sperm (16, 17). Although TESP1,
TESP2, and TESP4 are all present in the acrosome of mouse sperm,
Western blot analysis of sperm protein extracts indicates that the
three proteases differ from the 42-kDa gelatin-hydrolyzing enzyme in
molecular size. In addition, TESP3 is localized solely in spermatogenic
cells of the testis when antibody raised against the N-terminal
6-residue peptide of TESP3 is
used.2 These data imply that
none of the four TESPs is identical to the 42-kDa gelatin-hydrolyzing
protease. Thus, further experiments are required to elucidate the
mechanism of sperm penetration through the ZP in mouse.
In this study, we have isolated genomic clones encoding a testicular
serine protease, termed TESP5, from a mouse genomic DNA library. The
nucleotide sequence of the TESP5 gene demonstrates the
identity of this gene with the testisin (18) and
esp-1 (19) genes previously reported. TESP5/testisin/esp-1
is localized on the sperm membrane probably as a
glycosylphosphatidylinositol (GPI)-anchored protein, and corresponds to
the 42- and 41-kDa gelatin-hydrolyzing enzymes. On the basis of
biochemical data regarding TESP5, a possible role of TESP5 in the
sperm/egg interaction is discussed.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Triton X-100, Nonidet P-40, calcium
ionophore A23187, bovine pancreatic trypsin (type III, T-8253),
Bacillus cereus phosphatidylinositol-specific phospholipase
C (PI-PLC), and protease inhibitors, pAB, diisopropyl fluorophosphate,
N
-tosyl-L-lysine chloromethyl
ketone (TLCK), phenylmethanesulfonyl fluoride, and
N-tosyl-L-phenylalanine chloromethyl ketone
(TPCK) were purchased from Sigma. Ampholine (pH 3.5-10) and Immobiline DryStrip (pH 3-10, 7 cm) were purchased from Amersham
Biosciences. Monoclonal antibodies against acrosomal proteins of
mouse sperm, MN7 (20), and MC101 (21), were provided by Dr. K. Toshimori. Rabbit anti-mouse AKAP82 antiserum (22) was a gift from Dr. S. B. Moss. Protease substrates, t-butyloxycarbonyl
(Boc)-, N-succinyl (Suc)-, or carbobenzoxy
(Z)-peptidyl-4-methylcoumaryl-7-amide (MCA), were purchased from
Peptide Institute, Inc. (Osaka, Japan). Rat acrosin was purified from
cauda epididymal sperm, as described previously (15). Experimental
animals, ICR mice, Wistar rats, and New Zealand White rabbits, were
obtained from Japan SLC Inc. (Shizuoka, Japan).
Reverse Transcriptase-Polymerase Chain Reaction
(RT-PCR)--
RT-PCR was carried out using a 3'-Full RACE kit (Takara
Shuzo, Shiga, Japan) according to the manufacturer's protocol.
First-strand cDNA was synthesized from total cellular RNAs of
various tissues and male germ cells by AMV RT XL using an oligo
(dT)-3sites adaptor primer. PCR was carried out in a mixture (25 µl)
containing 10 mM Tris-HCl, pH 8.8, 50 mM KCl,
1.5 mM MgCl2, 0.1% Triton X-100, 0.2 mM each of dATP, dCTP, dGTP, and dTTP, 1 µM
each of the primers, the template DNA, and 2.5 units of Taq
DNA polymerase (Wako, Osaka, Japan). The PCR products were purified by
polyacrylamide gel electrophoresis (PAGE), and then introduced into a
pUC19 vector.
Isolation of Genomic Clones--
An expressed sequence tag (EST)
clone, AA144961, was amplified from a mouse testis cDNA library by
PCR using T6-1, 5'-CCTGCGGTCACAGGACCATCC-3', and T6-2,
5'-ACAGCTTCAGCAGGGCTATGTCA-3', as primers. The DNA fragment amplified
was labeled with [
-32P]dCTP (Amersham Biosciences),
and used as a probe to screen ~9.0 × 105 plaques
from a mouse 129/SvJ genomic DNA library in
FIXII (Stratagene), as
described previously (23). Phage DNAs were prepared from the positive
clones, digested by various restriction enzymes, and introduced into
pUC19 for further characterization. Nucleotide sequence analysis was
carried out using an ABI Prism 310 genetic analyzer.
Southern and Northern Blot Analysis--
DNAs and RNAs were
separated by agarose gel electrophoresis and transferred onto
Hybond-N+ nylon membranes (Amersham Biosciences), as
described previously (23). The blots were probed by
32P-labeled DNA fragments, and analyzed by a BAS-1800II
Bio-Image analyzer (Fuji Photo Film, Tokyo). To remove poly(A) tails of mRNAs, RNase H digestion of total RNAs, which had been annealed with oligo(dT)15, was carried out as described (24). The
RNase H-digested RNA samples were subjected to Northern blot analysis, as mentioned above.
Preparation of Crude Protein Extracts--
Mouse testes were
homogenized in 3 ml of phosphate-buffered saline (PBS) containing 1 mM EDTA, 1 mM benzamidine/HCl, 1 mM phenylmethanesulfonyl fluoride, leupeptin (1 µg/ml), and pepstatin A
(1 µg/ml) using a Teflon-glass homogenizer at 900 rpm (5 strokes/min). The homogenate was centrifuged in a Tomy SRX-201
centrifuge using a TA-24BH rotor (Tokyo, Japan) at 19,000 × g for 10 min. The supernatant solution was further
centrifuged at 19,000 × g for 10 min, and the
resulting supernatant was used as "soluble protein extracts." The
precipitate obtained by first centrifugation was extracted in PBS
containing 1% SDS at room temperature for 1 h, and then centrifuged at 16,000 × g for 10 min. The supernatant
was used as "insoluble protein extracts." Fresh cauda epididymal
sperm in a modified Krebs-Ringer bicarbonate solution (TYH medium, see Ref. 8) free of bovine serum albumin were incubated at 37 °C for 30 min under 5% CO2 in air. The dispersed sperm suspension was centrifuged in an Eppendorf 5415D centrifuge at 800 × g for 10 min, and the supernatant was discarded. The pellet
was washed, extracted in 1 mM HCl containing 1% SDS or 1%
Triton X-100 at room temperature for 1 h, and centrifuged in the
above Tomy centrifuge at 16,000 × g for 10 min. The
supernatant was subjected to SDS-PAGE and Western blot analysis.
Protein concentration was determined using a BCA protein assay reagent (Pierce).
Subcellular Fractionation of Sperm--
Subcellular components
of cauda epididymal sperm were prepared as described previously (15,
25) with minor modifications. Sperm were suspended in the TYH medium
containing calcium ionophore A23187 (10 µg/ml), incubated for 60 min
at 37 °C under 5% CO2 in air, and centrifuged twice in
an Eppendorf 5415D centrifuge at 800 × g for 10 min to
remove sperm. The supernatant was further separated into the
precipitate and supernatant fractions by centrifugation in a Beckman
L8-70M ultracentrifuge using an SW41 rotor at 100,000 × g for 90 min at 4 °C. The precipitate was washed with
PBS, centrifuged at 100,000 × g for 60 min, and
resuspended in PBS (Fraction A). The supernatant solution after first
ultracentrifugation was dialyzed against PBS, and centrifuged in the
above Eppendorf centrifuge at 13,000 × g for 10 min
(Fraction B). Fractions A and B were used as samples enriched by plasma
and outer-acrosomal membranes, and soluble proteins released by the
A23187-induced acrosome reaction, including acrosomal components,
respectively. Acrosome-reacted sperm were washed three times with PBS,
and sonicated as described (25). To the 2.5-ml suspension an equal
volume of 1.8 M sucrose was added, and the mixture was put
onto a discontinuous sucrose gradient solution containing 2.5 ml each
of 2.20 and 2.05 M sucrose, and centrifuged in the above
Beckman L8-70M ultracentrifuge at 100,000 × g for
16 h at 4 °C. Fractions C, D, and E corresponding to
acrosome-reacted sperm heads, tails, and cytoplasmic droplets formed a
pellet at the bottom of the centrifuge tube, a band at the middle of
the 2.05 M sucrose layer, and a band at the interface between the 0.9 and 2.05 M sucrose layers, respectively.
Each of Fractions D and E was precipitated by centrifugation at
100,000 × g. The purities of these fractions were
microscopically more than 95%. The samples were suspended in PBS,
mixed with an SDS sample buffer, and then subjected to Western blot analysis.
Preparation of Low Density Triton X-100-insoluble Membrane
Fractions--
Low density membrane fractions insoluble in Triton
X-100 were prepared from cauda epididymal sperm by the established
method (26) with minor modifications. Sperm (3.0 × 108 sperm/ml) were suspended in 10 mM Tris-HCl,
pH 7.5, 0.15 M NaCl, and 5 mM EDTA (TNE)
containing 75 units/ml aprotinin and 1% Triton X-100, and put on ice
for 20 min. The suspension was homogenized by a Dounce homogenizer (5 strokes), and centrifuged in an Eppendorf 5415D centrifuge at
2,000 × g for 5 min to remove nuclei and cell debris.
The supernatant solution was brought to 40% sucrose using 80% sucrose
in TNE, placed at the bottom of a Beckman Ultra Clear centrifuge tube,
and overlaid with 30% sucrose (6 ml) and 5% sucrose (3.5 ml) in TNE.
After centrifugation in a Beckman L8-70M ultracentrifuge using an SW41
rotor at 200,000 × g for 18 h, fractions (1 ml) were collected from the top to the bottom of the gradient, and then
subjected to SDS-PAGE in the presence of 0.1% gelatin.
Production of Recombinant Proteins--
An 871-bp DNA fragment
encoding the pro- and catalytic domains of TESP5 was PCR-amplified from
a mouse testis cDNA library, using MTP4, 5'-TGCGGCCATGGCCTTACA-3',
and MTP5, 5'-AACTCGAGTTAGTCAGGCCTGAGCAGCC-3', as primers. The PCR
product was introduced into a pET-23d vector (Novagen, Madison, WI) at
the NcoI and XhoI sites for expression in
Escherichia coli BL21 (DE3). A single colony of the
transformants was cultured at 37 °C overnight in Luria broth
containing 0.1 mg/ml ampicillin (5 ml, LA) with constant shaking. A
portion (3 ml) of the bacterial culture was added to fresh LA (120 ml),
and incubated at 37 °C for 2 h with shaking. Production of the
recombinant proteins was induced by addition of 0.3 ml of 0.1 M
isopropyl-1-thio-
-D-galactopyranoside, and the cell
growth was continued at 20 °C overnight. E. coli cells
were collected by centrifugation in a Tomy RL-131 centrifuge using a
TS-7 rotor at 1,500 × g for 10 min, and suspended in
10 mM sodium phosphate, pH 7.4, containing 30 mM NaCl, 10 mM 2-mercaptoethanol, 10 mM EDTA, and 0.25% Tween 20. The suspension was frozen at
80 °C, sonicated, and then centrifuged in a Tomy SRX-201
centrifuge using a TA-24BH rotor at 10,000 × g for 10 min at 4 °C. Recombinant TESP5 was found as an enzymatically
inactive protein solely in the precipitate.
For production of recombinant TESP5 in a mammalian cell line, HEK293,
an expression plasmid carrying the entire protein-coding region in the
TESP5 cDNA sequence was constructed by PCR-directed mutagenesis
using a set of oligonucleotide primers, MTP2,
5'-TGAATTCACAGGTGTGACGTACAC-3', and MTP3,
5'-TTGAATTCGAGAGGTGGCCATGGGC-3'. The amplified DNA fragment was
introduced into a pCXN2 (27) vector at the EcoRI site.
HEK293 cells (4 × 106 cells), which were maintained
in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10%
fetal bovine serum, 100 units/ml penicillin, and 0.1 mg/ml streptomycin
at 37 °C under 5% CO2 in air, were electroporated at
500 µF with the expression plasmid (10 µg) in PBS, and viable cells
were plated in 35-mm culture dishes. After 24 h, cells were
treated with trypsin and grown in the above medium containing 0.5 mg/ml
G418 to obtain stable transformants.
Preparation of Antibody--
Recombinant mouse TESP5 (0.5 mg)
produced in E. coli was emulsified by sonication in an equal
volume of Freund's complete adjuvant (Difco Laboratories), and
injected intradermally into female rabbits. Rabbit anti-TESP5
antibody was purified by fractionation with ammonium sulfate (0-40%
saturation) followed by immunoaffinity chromatography on a column of
Sepharose 4B that had been substituted with the recombinant protein by
the cyanogen bromide procedure (28), as described (23).
SDS-PAGE and Western Blot Analysis--
Proteins were separated
by SDS-PAGE under non-reducing conditions and transferred onto
Immobilon-P polyvinylidene difluoride membranes (Millipore). After
blocking with 2% skim milk, the blots were incubated with
affinity-purified anti-TESP5 antibody at room temperature for 2 h,
and then incubated with horseradish peroxidase-conjugated goat
anti-rabbit IgG (Jackson Immunoresearch Laboratories) for 1 h. The
immunoreactive proteins were detected by an ECL Western blotting
detection kit (Amersham Biosciences). To detect proteins exhibiting
gelatin-hydrolyzing activities, SDS-PAGE in the presence of 0.1%
gelatin was carried out as described previously (15).
Two-dimensional PAGE--
Proteins (0.2 mg) were pre-incubated
in 50 mM Tris-HCl, pH 8.5, at room temperature for 3 h, lyophilized, dissolved in 8 M urea (120 µl) containing
0.5% Triton X-100 and 0.5% Ampholine (pH 3.5-10), and placed onto
polyacrylamide gel strips with an immobilized pH gradient (Immobiline
DryStrips) at 20 °C for 10 h. Isoelectric focusing was carried
out at 20 °C using an IPGphor instrument (Amersham Biosciences)
according to the following program: a linear gradient run at 0 to 500 V
for 60 min, 500 to 1,000 V for 60 min, and 1,000 to 8,000 V for 60 min,
and a constant run at 8,000 V for 3 h. After electrophoresis, the
gel strips were soaked in 50 mM Tris-HCl, pH 6.8, containing 6 M urea, 30% glycerol, and 1% SDS, and then
subjected to SDS-PAGE.
Immunoprecipitation--
Affinity-purified anti-TESP5 antibody
(30 µl) was incubated at 4 °C for 1 h in 0.5 ml of PBS
containing 0.5% Nonidet P-40 and 6 µl of protein A immobilized on
agarose beads (Pierce). The agarose beads were washed with PBS by
centrifugation to remove the unbound antibodies, mixed with sperm
proteins (0.2 mg) in 0.5 ml of PBS containing 0.5% Nonidet P-40,
incubated at 4 °C overnight, and centrifuged. The pellet was washed
three times with PBS containing 0.5% Nonidet P-40, dissolved in 8 M urea, and then subjected to SDS-PAGE.
Immunostaining of Testicular Sections and Sperm--
Testicular
tissues from adult mice were fixed in a solution containing 50 mM sodium phosphate, pH 7.4, 0.1 M lysine
hydrochloride, and 2% paraformaldehyde (PLP) at 4 °C for 3 h,
snap-frozen, and embedded in a Tissue-TekTM O.C.T. compound
(Sakura Finetechnical Co., Tokyo). Sections (7 µm) were prepared in a
Leica CM3000 cryostat, mounted on silanized glass slides, air-dried at
room temperature, and washed with PBS. Each slide for the testicular
sections was blocked with 2% normal goat serum in PBS, and incubated
with affinity-purified anti-TESP5 antibody in PBS containing 0.05%
bovine serum albumin at 4 °C overnight. After washing with PBS, the
slides were treated with 0.3% hydrogen peroxide to remove endogenous
peroxidase activity, washed with PBS, and incubated with horseradish
peroxidase-conjugated goat anti-rabbit IgG. The samples on the slides
were stained with 3,3'-diaminobenzidine as a chromogen, counterstained
with 2.5% methyl green, and viewed under an Olympus BX50 microscope.
Indirect immunofluorescence microscopy of cauda epididymal sperm was
carried out as described previously (9). Briefly, sperm samples on slides, which had been fixed in PLP, were incubated with the primary antibodies overnight, washed with PBS, and treated with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Jackson Immunoresearch Laboratories) for 4 h. After washing with PBS, the slides were observed using an Olympus BX50 fluoromicroscope.
Measurement of Enzyme Activity--
Enzyme activity was measured
using various Boc-, Suc-, or Z-peptidyl-MCAs as substrates, as
described previously (8). The reaction mixture (0.5 ml) consisted of 50 mM Tris-HCl, pH 8.0, 10 mM CaCl2,
40 µM substrate, and an appropriate amount of enzyme. Following incubation at 30 °C for 30 min, the reaction was
terminated by addition of 0.1 M acetate buffer, pH 4.3 (1.5 ml). The amounts of 7-amino-4-methylcoumarin formed were
fluorometrically determined using excitation at 380 nm and emission at
460 nm.
 |
RESULTS |
To identify genes encoding novel serine proteases present in mouse
sperm, we initially searched the EST data base derived from the mouse
testis. An EST clone, GenBankTM accession number AA144961,
was found to code for a serine protease, termed TESP5, that did not
correspond to acrosin and four TESPs. Thus, a 326-bp DNA fragment in
the TESP5 cDNA sequence was amplified by RT-PCR using mouse
testicular RNA as a template, and used as a probe to screen a mouse
129/SvJ genomic DNA library. Two positive clones, HGC3 and HGC14, which
overlap to each other, have been identified (Fig.
1A). The DNA sequence
indicated that the mouse TESP5 gene is ~4.5 kbp in length,
and consists of six exons interrupted by five introns. Southern blot
analysis also demonstrated that this gene is a single copy gene on the
mouse genome (Fig. 1B).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Exon/intron organization of the mouse
TESP5 gene, potential structure of prepro-form of
TESP5, and Southern blot analysis of mouse genomic DNA. A,
gene and protein structures of mouse TESP5. Two genomic clones, HGC3
and HGC14, encoding the TESP5 gene have been identified from
a mouse genomic DNA library. The TESP5 gene is ~4.5 kbp in
length, and consists of six exons (closed boxes) interrupted
by five introns. Restriction enzyme sites are as follows: G,
BglII; E, EcoRI; H,
HindIII. The prepro-form of mouse TESP5 is a single-chain
324-residue polypeptide containing three domains (DI, DII, and DIII).
The disulfide-bond arrangements (C-C) and positions of three
active-site residues, His, Asp, and Ser, are based on the sequence
similarity of TESP5 with other serine proteases. Potential
N-glycosylation sites are indicated by Y symbols.
B, Southern blot analysis of mouse genomic DNA. Mouse
genomic DNAs digested by BglII (G),
EcoRI (E), and HindIII (H)
were separated by agarose gel electrophoresis and transferred onto
nylon membranes. The blots were probed by a 32P-labeled DNA
fragment encoding a part of sixth exon.
|
|
A computer search for known genes deposited in the
GenBankTM Data Bank revealed that the mouse
TESP5 gene (data not shown, see GenBankTM
accession number AB059414) was 98.5 and 99.9% homologous to the
testisin (AF304012, see Ref. 18) and esp-1
(AB041645, see Ref. 19) genes, respectively, the former of which was
most recently characterized as a possible suppressor gene for
non-classical type II tumor (29). The differences of the DNA sequences
among these three genes were present only in the 5'-flanking region, second, fourth, and fifth introns, and 3'-untranslated region in sixth
exon (data not shown). Indeed, the composite sequence of six exons in
the TESP5 gene perfectly matched with the testisin cDNA
sequence (AY005145). Thus, we conclude that these three genes are the same.
The DNA-derived amino acid sequence indicated that mouse
TESP5/testisin/esp-1 is initially synthesized as a single-chain
324-residue polypeptide with a calculated molecular mass of 36,175 Da
(Fig. 2A). The N-terminal
21-residue sequence (DI in Figs. 1A and 2A) of
the TESP5/testisin/esp-1 prepro-protein was predicted to be a signal
peptide for a nascent secretory protein because of the hydrophobic
profile (data not shown), suggesting that the pro-form (zymogen) of
TESP5 may start with Leu at residue 22. Alignment of the entire
sequence of mouse TESP5 with those of human testisin, human
chymotrypsin, and mouse trypsin indicated the conservation of Cys
residues, three active-site residues, His, Asp, and Ser, required for
the proteolytic activity of serine proteases (30), and a substrate
recognition residue, Asp, for the Arg/Lys-Xaa bond cleavage (31).
Moreover, TESP5 contained the
Cys-Gly-His-Arg-Thr-Ile-Pro-Ser-Arg (residues 46-54) and Ile-Val-Gly-Gly sequences (residues 55-58) in
DII and DIII (Figs. 1A and 2A), which are highly
similar or identical to the typical sequences of a pro-enzyme segment
(activation peptide) of serine protease zymogens, including
chymotrypsinogen, and of an activated serine protease at the N terminus
(30), respectively. Thus, the TESP5 zymogen appears to be a
single-chain polypeptide of 303 amino acids containing a possible
33-residue pro-part (DII) of the zymogen at the N terminus. A highly
hydrophobic sequence of ~20 residues, which may function as a direct
anchor to the plasma membrane or as a signal sequence for attachment to
GPI, was present at the C terminus of TESP5 (Fig. 2B).

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 2.
Comparison of the amino acid sequence of
mouse TESP5 with those of other serine proteases and GPI-anchored
proteins. A, sequence alignment of TESP5 with human
testisin, human chymotrypsin, and mouse trypsin. As described in the
legend to Fig. 1A, the prepro-form of mouse TESP5 is a
324-residue polypeptide containing three domains (DI, DII, and DIII).
Dashes represent gaps introduced to optimize the alignment.
Identical residues in the sequences between TESP5 and other proteases
are shown by shaded boxes. Closed and open arrows
indicate the defined or putative cleavage sites during initial transfer
of the nascent protein to the endoplasmic reticulum and during
activation of the serine protease zymogens, respectively. The locations
of Cys residues (open circles) and three active-site
residues (closed circles) as a serine protease are also
represented above the sequence. Closed triangles indicate
potential N-glycosylation sites. B, sequence
alignment of TESP5 with five GPI-anchored proteins. The C-terminal
sequence of TESP5 is compared with those of rat Thy-1, human alkaline
phosphatase (APase), Drosophila acetylcholinesterase (AChE),
chicken N-CAM, and guinea pig PH20. Arrows represent
possible or defined GPI-attachment sites.
|
|
Two mRNA signals with sizes of 1.5 and 1.3 kb were found by
Northern blot analysis exclusively in the testis among the mouse tissues tested (Fig. 3A), and
in pachytene spermatocytes and round spermatids (Fig. 3B).
Only a single 1.2-kb mRNA signal was detected when the RNA samples
were annealed with oligo(dT)15 and digested with RNase H. Thus, the difference of the two mRNAs is most likely due to the
length of the poly(A) tail. RT-PCR analysis, using a set of
oligonucleotides, T6-1 and T6-2, as primers, revealed the initial
transcription of the TESP5 gene in the testis at 18th day
after birth (data not shown). These data demonstrate specific expression of the mouse TESP5 gene in pachytene
spermatocytes and round spermatids.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Northern blot analysis of total cellular RNAs
from various tissues and purified populations of spermatogenic
cells. A, Northern blot analysis of total RNAs (10 µg) from mouse testis (T), brain (B), lung
(Lu), heart (H), liver (Li), kidney
(K), ovary (O), and uterus (U). The
blots were first probed by a 32P-labeled DNA fragment
encoding mouse TESP5, and then re-probed by the DNA fragment coding for
mouse glyceraldehyde-3-phosphate dehydrogenase (GDH).
B, removal of mRNA poly(A) tails by RNase H treatment.
Total RNAs (12 µg) of pachytene spermatocytes (P), round
spermatids (R), and a mixture of elongating spermatids and
residual bodies (E) from 60-day-old mouse testes were
annealed with oligo(dT)15, treated with RNase H, and then
subjected to Northern blot analysis. The blots were probed by a
32P-labeled DNA fragment encoding mouse TESP5.
|
|
Little is known of the functions of testicular testisin (18, 29) and
eosinophilic esp-1 (19), because the experimental data have been still
restricted to the structure, organization, and chromosomal assignment
of the gene, and the protein localization in testicular cells. Thus, we
first carried out Western blot analysis of soluble and insoluble
proteins from testicular tissues, and of detergent-soluble proteins
from cauda epididymal sperm, using affinity-purified anti-TESP5
antibody as a probe (Fig. 4A).
Two immunoreactive proteins with sizes of 43 and 42 kDa were detected only in the insoluble protein extracts of testis, whereas the sperm
extracts gave two bands corresponding to the 42- and 41-kDa proteins.
In addition, two-dimensional PAGE of the sperm Triton X-100 extracts
indicated that the 42- and 41-kDa forms of TESP5 with the isoelectric
points (pI) of 5.0 to 5.5 exhibit gelatin-hydrolyzing activity (Fig.
4B). These results imply the presence of TESP5 on the
membranes of sperm as well as of testicular germ cells. Most
importantly, the molecular sizes and pI values of the two forms of
TESP5 are consistent with those of 42- and 41-kDa serine proteases that
was identified as candidate proteins necessary for sperm penetration of
the egg ZP in mouse (8, 14, 15).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Western blot analysis of protein extracts
from mouse testis and sperm. A, Western blot analysis of
soluble and insoluble proteins (30 µg) from testicular tissues, and
of detergent-soluble proteins (20 µg) from cauda epididymal sperm,
using affinity-purified anti-TESP5 antibody as a probe. Proteins were
separated by SDS-PAGE under non-reducing conditions, and subjected to
Western blot analysis using affinity-purified anti-TESP5 antibody. Two
immunoreactive proteins with sizes of 43 and 42 kDa were detected only
in the insoluble protein extracts of testis, whereas the sperm extracts
solubilized with 1% SDS or 1% Triton X-100 (TX-100) gave
two bands corresponding to 42- and 41-kDa proteins. B,
Western blot analysis of Triton X-100-soluble proteins from cauda
epididymal sperm, using affinity-purified anti-TESP5 antibody as a
probe. Proteins (0.2 mg) were separated by two-dimensional PAGE under
non-reducing conditions, and subjected to Western blot analysis
(left panel) or SDS-PAGE in the presence of gelatin
(right panel). Closed and open
arrowheads indicate the locations of the immunoreactive and
gelatin-hydrolyzing proteins, respectively.
|
|
To ascertain whether TESP5 is identical to the 42- and 41-kDa sperm
serine proteases (8, 14, 15), proteins in sperm Triton X-100 extracts
immunoprecipitated with affinity-purified anti-TESP5 antibody, and then
subjected to SDS-PAGE in the presence of gelatin (Fig.
5). Two gelatin-hydrolyzing proteins with
molecular masses of 42 and 41 kDa were clearly found in the
immunoprecipitates. No significant band was detectable when
affinity-purified anti-mouse sp32 antibody (23) was used for the
immunoprecipitation as a control. Thus, these data demonstrate the
identity between TESP5/testisin/esp-1 and the 42- and 41-kDa sperm
serine proteases.

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 5.
Immunoprecipitation of TESP5 from protein
extracts of mouse sperm. Triton X-100-soluble extracts (0.2 mg of
proteins) of cauda epididymal sperm were used for immunoprecipitation
of TESP5 in the absence (lane 2) or presence of
affinity-purified antibodies against mouse sp32 (lane 3) and
mouse TESP5 (lane 4). The sperm protein extracts were also
used as a positive control (lane 1). Aliquots of the
immunoprecipitates were separated by SDS-PAGE under non-reducing
conditions, and subjected to Western blot analysis using
affinity-purified anti-TESP5 antibody (A) and SDS-PAGE in
the presence of gelatin (B). The immunoreactive proteins
with sizes of 42 and 41 kDa exhibiting the gelatin-hydrolyzing activity
were found only in lanes 1 and 4.
|
|
When sections of adult mouse testis were immunohistochemically analyzed
using the affinity-purified anti-TESP5 antibody, the signals were
observed in round and elongating spermatids in the seminiferous tubules
(panels a and b in Fig.
6A). In particular, the
granular signals with a great intensity were found in elongating spermatids. Spermatogonia, pachytene spermatocytes, and Sertoli cells
gave no signal at detectable level. Indirect immunofluorescence assay
of acrosome-intact sperm revealed the presence of strong and weak
signals in the cytoplasmic droplet, and in the head and midpiece of
sperm, respectively (panels c and d in Fig.
6A). The immunofluorescence signals disappeared in the
presence of the recombinant TESP5 protein (panels e and
f). To verify the localization of TESP5, proteins in five
subcellular fractions (Fractions A to E) of mouse sperm (see
"Experimental Procedures") were examined by Western blot analysis
using antibodies against an acrosomal proacrosin-binding protein, sp32
(23), a 90-kDa intra-acrosomal protein, MN7 (20), a 155-kDa
intra-acrosomal protein, MC101 (21), and a protein kinase A anchor
protein, AKAP82 (22), in the flagellum fibrous sheath, as markers (Fig.
6B). The 42- and 41-kDa forms of TESP5 were found in all
five fractions, including Fractions A (plasma and outer-acrosomal
membranes), B (soluble proteins released by acrosome reaction including
acrosomal components), and C (acrosome-reacted sperm heads). Thus,
these results demonstrate that TESP5 is localized in the sperm head,
cytoplasmic droplet, and midpiece probably as a membranous protein.
However, it is unclear whether TESP5 is partly present as a soluble
protein in the sperm acrosome.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 6.
Location of TESP5 in mouse testis and cauda
epididymal sperm. A, immunohistochemical
analysis of testicular sections (a and b) and
indirect immunofluorescence assay of epididymal sperm
(c, d, e, and f). For
immunohistochemistry, sections of mouse testis were probed by
affinity-purified anti-TESP5 antibody using 3,3-diaminobenzidine as a
chromogen. The sections were counterstained with methyl green
(a, ×400; b, ×1,000). Red arrows
indicate the location of granular signals with a great intensity in
elongating spermatids. Indirect immunofluorescence assay of
acrosome-intact sperm was also carried out in the absence (c
and d) or presence (e and f) of
recombinant TESP5. The immunofluorescence signals in the sperm head
(arrowheads), midpiece, and cytoplasmic droplet
(arrows) disappeared in the presence of the recombinant
protein (f). The phase-contrast (c and
e) and immunofluorescence (d and f)
views are represented. B, Western blot analysis of proteins
in subcellular components of cauda epididymal sperm. Proteins in the
sperm subcellular components enriched by plasma and outer-acrosomal
membranes (Fraction A), soluble proteins released by the A23187-induced
acrosome reaction, including acrosomal components (Fraction B),
acrosome-reacted sperm heads (Fraction C), tails (Fraction D), and
cytoplasmic droplets (Fraction E, see "Experimental Procedures")
were analyzed by Western blotting using affinity-purified anti-TESP5
antibody. Antibodies against an acrosomal proacrosin-binding protein,
sp32, a 90-kDa intra-acrosomal protein, MN7, a
155-kDa intra-acrosomal protein, MC101, and a protein kinase
A anchor protein, AKAP82, in the flagellum fibrous sheath,
were also used as markers. Note that the 42- and 41-kDa forms of TESP5
are detected in all five fractions.
|
|
Preferential clustering of sphingolipids and cholesterol in the lipid
bilayers of cell membranes is known to form organized compositional
microdomains, "rafts," that move within the fluid bilayer (32, 33).
GPI-anchored, transmembrane, and lipid-linked proteins can be
selectively included into lipid rafts that are insoluble in non-ionic
detergents such as Triton X-100. Western blot analysis indicated the
presence of 42- and 41-kDa forms of TESP5 exhibiting
gelatin-hydrolyzing activity in the Triton X-100-insoluble, low-density
membrane fractions (lanes 7 and 8) from mouse
sperm (Fig. 7). Judging by the
intensities of the immunoreactivities with affinity-purified anti-TESP5
antibody, only a small amount of TESP5 was found in the Triton
X-100-soluble fractions (lanes 1 and 2). Thus,
TESP5 is mostly included into lipid rafts of the sperm membrane.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 7.
TESP5 is selectively included into Triton
X-100-insoluble, low-density membrane fractions of mouse sperm.
Low-density membrane fractions insoluble in Triton X-100 were prepared
from cauda epididymal sperm. An aliquot (10 µl) of the fractions was
analyzed by Western blotting using affinity-purified anti-TESP5
antibody (A) or SDS-PAGE in the presence of gelatin
(B). The 42- and 41-kDa forms of TESP5 exhibiting
gelatin-hydrolyzing activity are found in the Triton X-100-insoluble,
low-density membrane fractions (lanes 7 and
8).
|
|
To prepare enzymatically active TESP5, HEK293 cells were transformed by
introducing an expression plasmid carrying the entire protein-coding
region of TESP5. The recombinant protein produced was
effectively released from the cell membrane by treatment with exogenous
bacterial PI-PLC, and exhibited a relatively strong activity for
gelatin hydrolysis (Fig. 8). However, the
molecular size of the recombinant protein was ~4 kDa larger than
those of the native proteins in the testis and sperm (Fig.
4A). This discrepancy may be explained by the structural
and/or numerical differences of carbohydrate side chains between the
recombinant and native proteins. At any rate, these data demonstrate
that TESP5 is GPI-anchored on the membrane of at least HEK293
cells.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 8.
Release of recombinant TESP5 from the
membrane of HEK293 cells by Bacillus cereus
phosphatidylinositol-specific phospholipase C (PI-PLC).
Transformed HEK293 cells (5 × 106 cells in 0.1 ml of
PBS) were incubated at 37 °C for 1 h in the absence or presence
of bacterial PI-PLC (0.1 or 1.0 units/ml), and centrifuged. Aliquots
(10 µl) of the supernatants were subjected to SDS-PAGE in the
presence of gelatin under non-reducing conditions. Western blot
analysis was carried out using affinity-purified anti-TESP5 antibody.
M, mock transformants; T, TESP5
transformants.
|
|
Proteolytic activity of recombinant TESP5 released by PI-PLC treatment
was measured using various peptidyl-MCAs as substrates (Fig.
9A). For comparison, rat sperm
acrosin and bovine pancreatic trypsin were also used. These three
proteins exhibited the maximum activity toward Boc-Phe-Ser-Arg-MCA
among the substrates tested. TESP5 was distinguished from acrosin and
trypsin by the substrate specificity; TESP5 was capable of hydrolyzing
Boc-Leu-Thr-Arg-MCA and Boc-Ala-Gly-Pro-Arg-MCA (typical substrates for
factor VIIa-Tf and processing enzyme of atrial natriuretic peptide
precursor, respectively) as effectively as Boc-Phe-Ser-Arg-MCA. No
enzyme activity was detected in these three proteases when
Suc-Ala-Ala-Ala-MCA, Suc-Ile-Ile-Trp-MCA, Suc-Leu-Leu-Val-Tyr-MCA, and
Z-Val-Lys-Met-MCA, typical substrates for elastase, endothelin,
chymotrypsin, and amyloid A4 generating enzyme, respectively, were used
(data not shown). Moreover, the inhibition profile of TESP5 was similar to those of acrosin and trypsin, except that the proteolytic activity of TESP5 was inhibited by TLCK to a relatively low extent (Fig. 9B). However, the inhibitory effects of pAB, diisopropyl
fluorophosphate, TLCK, and phenylmethanesulfonyl fluoride on the TESP5
activity were consistent with our previous results obtained by SDS-PAGE in the presence of gelatin (14).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 9.
Substrate specificity of TESP5 and inhibitory
effects of various serine protease inhibitors on the TESP5
activity. A, substrate specificity of TESP5. The enzyme
activities of recombinant TESP5, rat acrosin, and bovine pancreatic
trypsin were measured using Boc-Phe-Ser-Arg-MCA (F-S-R),
Boc-Val-Pro-Arg-MCA (V-P-R), Boc-Leu-Thr-Arg-MCA
(L-T-R), and Boc-Ala-Gly-Pro-Arg-MCA (A-G-P-R) as
substrates. The enzyme reactions were carried out at 30 °C for 30 min, and terminated by addition of 0.1 M acetate buffer, pH
4.3. The enzyme activity toward Boc-Phe-Ser-Arg-MCA is indicated as
100%. Data are expressed as the mean ± S.D., where
n > 3. B, effects of serine protease
inhibitors on enzyme activity of TESP5. The enzyme activity was
measured in the presence of 1 mM each of pAB, diisopropyl
fluorophosphate (DFP), TLCK, phenylmethanesulfonyl fluoride
(PMSF), and TPCK using Boc-Phe-Ser-Arg-MCA as a substrate,
as described above. The enzyme activity in the absence of any
inhibitors (None) is indicated as 100%. Data are expressed
as the mean ± S.D., where n > 3.
|
|
 |
DISCUSSION |
This study describes the identity of TESP5 with testicular
testisin and eosinophilic esp-1 (Figs. 1 and 2), and with 42- and 41-kDa sperm serine proteases (Figs. 4 and 5) that may participate in
the limited proteolysis of the egg ZP in fertilization, instead of
and/or in cooperation partly with acrosin (8, 9, 14, 15). TESP5 is
localized on the membranes of testicular germ cells and cauda
epididymal sperm (Figs. 4 and 6). Particularly, the 42- and 41-kDa
forms of TESP5 are selectively included into lipid rafts of sperm
membranes presumably as a GPI-anchored protein (Fig. 7). Since lipid
rafts are thought to function in signal transduction at the cell
surface in response to intra- and extracellular stimuli (32-37), it is
conceivable that TESP5 plays an important role(s) in the sperm/egg
interactions, including the sperm penetration of the ZP.
Human testisin was originally identified as a candidate for
non-classical type II tumor suppressor, since expression of the testisin gene is completely lost in the testicular tumors
(29). A possible function of both human and mouse testisins has been speculated to participate in proteolytic cleavage and release of
biologically active molecules required for spermatogenesis, including
the migration of maturing germ cells in the seminiferous tubules
(18, 29). However, the expression pattern during spermatogenesis is
highly divergent between these two genes (proteins); human testisin is
localized only in pre-meiotic spermatocytes (29), whereas the
occurrence of the mouse protein is specific for haploid germ cells
(18). These data imply that the function of mouse testisin in germ
cells may be essentially different from that of the human protein. The
roles of human and mouse testisins in fertilization are unknown at all,
since the presence of the proteins in sperm has not been examined
minutely. In the present study, our data concerning the localization of
TESP5 in lipid rafts of the sperm membranes suggest that at least in
the mouse, TESP5/testisin is probably implicated rather in
fertilization than in spermatogenesis.
Although 42- and 41-kDa gelatin-hydrolyzing serine proteases have been
supposed to be different proteins (8, 14, 15), Western blot analysis
indicates that the 41-kDa form of TESP5 is likely to be a processed
form of the 42-kDa protein (Figs. 4 and 5). However, it is unclear at
present whether the 42-kDa form corresponds to the TESP5 zymogen, and
whether the zymogen itself is converted by autoactivation into
enzymatically active form(s). As shown in Fig. 4, two 43- and 42-kDa
proteins, which immunoreact with affinity-purified anti-TESP5 antibody,
are present in the testicular extracts. Our preliminary experiments
indicate that the two testicular proteins exhibit no
gelatin-hydrolyzing activity.3 These results
suggest that the zymogen(s) of TESP5 may correspond to the 43- or
42-kDa protein or both present in the testis, and may barely have the
ability to autoactivate itself. Acrosin perhaps functions partly as a
processing enzyme to convert the TESP5 zymogen(s) into the active 42- and 41-kDa proteins. If so, the insufficient ability of the TESP5
zymogen(s) in conversion into the active enzymes in the absence of
acrosin (14) seems to explain the fact that the sperm penetration of
the egg ZP is delayed in the acrosin-deficient mouse (8).
Regardless of treatment with exogenous pancreatic trypsin,
extracts of rat and hamster sperm contain no gelatin-hydrolyzing protein corresponding to mouse TESP5 (15). When the rat sperm extracts
were analyzed by Western blotting, only a single protein with a
molecular mass of 43 kDa and a pI value of 6.0 to 6.5 indeed immunoreacted with affinity purified anti-mouse TESP5
antibody.3 However, no gelatin-hydrolyzing activity of the
rat 43-kDa protein was found even if the rat sperm extracts were
treated with exogenous pancreatic trypsin. These data are entirely
consistent with the previous observation (15) that the 42- and 41-kDa
gelatin-hydrolyzing proteases (TESP5/testisin) are present specifically
in mouse sperm, and emphasize that the system of sperm serine proteases
is highly different between mouse and other animals, including rat and hamster.
Recombinant TESP5 produced in HEK293 cells is readily released from the
cell surface by treatment with bacterial PI-PLC (Fig. 8), suggesting
that the C-terminal hydrophobic sequence of TESP5 (Fig. 2) functions as
the signal sequence required for attachment to GPI at least in HEK293
cells. To ascertain whether TESP5 is GPI-anchored on the sperm
membrane, mouse cauda epididymal sperm were treated with bacterial
PI-PLC, and the released proteins were analyzed by Western blotting.
Sperm TESP5 was resistant to the PI-PLC treatment, as reported in mouse
TESP1 and TESP2 (16), and rat 2B1 glycoprotein (PH-20, see Ref. 38).
The reason for this discrepancy may be due to a possible
modification(s) of GPI anchors on the sperm membrane, including the
attachment of an extra fatty acid to the inositol ring, as described
previously (39, 40). The resistance of some sperm GPI-anchored proteins to PI-PLC possibly implies the protection of the proteins from the
attack of PI-PLC-like enzymes because of the physiological importance
in the sperm/egg interactions.
The mechanism of sperm penetration through the egg ZP is not completely
elucidated yet. Since TESP5 (42- and 41-kDa serine proteases) is the
most predominant serine protease in mouse sperm, further
characterization of TESP5 will be necessary to understand the molecular
events in the sperm/egg interactions, including the sperm penetration
through the ZP.
 |
ACKNOWLEDGEMENTS |
We thank Drs. K. Toshimori and S. B. Moss for kind gifts of monoclonal antibodies MN7 and MC101, and rabbit
anti-AKAP82 antiserum, respectively.
 |
Note Added in Proof |
After this paper was accepted for
publication, it has come to our attention that TESP5 as well as
testisin and esp-1 is also identical to tryptase 4 (GenBankTM accession numbers AF226710 and AF176209, see
Ref. 41). These four proteins belong to a 21st member of serine
protease family Prss21 (GenBankTM LocusID number 57256).
Moreover, tryptase 4 was shown to be expressed in the testis, to be
associated with a membrane fraction, and to exhibit the tryptase
activity (41).
 |
FOOTNOTES |
*
This work was supported in part by grant-in-aids for
Scientific Research on Priority Area (B), Scientific Research (A), and Exploratory Research from Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number(s) AB059414 and AB059415.
Present address: Genome Information Research Center, Osaka
University, Yamadaoka 3-1, Suita, Osaka 565-0871, Japan.
§
To whom correspondence should be addressed: Institute of Applied
Biochemistry, University of Tsukuba, Tsukuba Science City, Ibaraki
305-8572, Japan. Tel./Fax: 81-298-53-6632 or 6599; E-mail: acroman@sakura.cc.tsukuba.ac.jp.
Published, JBC Papers in Press, February 22, 2002, DOI 10.1074/jbc.M112470200
2
S. Sato and T. Baba, unpublished data.
3
A. Honda and T. Baba, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
ZP, zona pellucida;
Boc, t-butyloxycarbonyl;
GPI, glycosylphosphatidylinositol;
MCA, 4-methylcoumaryl-7-amide;
pAB, p-aminobenzamidine;
PBS, phosphate-buffered saline;
PI-PLC, phosphatidylinositol-specific
phospholipase C;
RT, reverse transcriptase;
Suc, N-succinyl;
TESP, testicular serine protease;
TLCK, N
-tosyl-L-lysine
chloromethyl ketone;
TPCK, N-tosyl-L-phenylalanine chloromethyl ketone;
Z, carbobenzoxy.
 |
REFERENCES |
| 1.
|
Yanagimachi, R.
(1994)
in
The Physiology of Reproduction
(Knobil, E.
, and Neill, J., eds)
, pp. 189-317, Raven Press, New York
|
| 2.
|
Wassarman, P. M.
(1999)
Cell
96,
175-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Wassarman, P. M.,
Jovine, L.,
and Litscher, E. S.
(2001)
Nature Cell Biol.
3,
E59-E64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Ward, C. R.,
and Kopf, G. R.
(1993)
Dev. Biol.
158,
9-34[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Bedford, J. M.
(1998)
Biol. Reprod.
59,
1275-1287[Free Full Text]
|
| 6.
|
Baba, T.,
Kashiwabara, S.,
Watanabe, K.,
Itoh, H.,
Michikawa, Y.,
Kimura, K.,
Takada, M.,
Fukamizu, A.,
and Arai, Y.
(1989)
J. Biol. Chem.
264,
11920-11927[Abstract/Free Full Text]
|
| 7.
|
Klemm, U.,
Müller-Esterl, W.,
and Engel, W.
(1991)
Hum. Genet.
87,
635-641[Medline]
[Order article via Infotrieve]
|
| 8.
|
Baba, T.,
Azuma, S.,
Kashiwabara, S.,
and Toyoda, Y.
(1994)
J. Biol. Chem.
269,
31845-31849[Abstract/Free Full Text]
|
| 9.
|
Yamagata, K.,
Murayama, K.,
Okabe, M.,
Toshimori, K.,
Nakanishi, T.,
Kashiwabara, S.,
and Baba, T.
(1998)
J. Biol. Chem.
273,
10470-10474[Abstract/Free Full Text]
|
| 10.
|
Stambaugh, R.,
Brackett, B. G.,
and Mastroianni, L.
(1969)
Biol. Reprod.
1,
223-227[Abstract]
|
| 11.
|
Zaneveld, L. J. D.,
Polakoski, K. L.,
Robertson, R. T.,
and Williams, W. L.
(1971)
Proceedings of the First International Conference on Proteinase Inhibitors
, pp. 236-244, Walter de Gruyter, Berlin
|
| 12.
|
Fraser, L. R.
(1982)
J. Reprod. Fertil.
65,
185-194[Abstract/Free Full Text]
|
| 13.
|
Miyamoto, H.,
and Chang, M. C.
(1973)
Biol. Reprod.
9,
533-537[Abstract]
|
| 14.
|
Yamagata, K.,
Murayama, K.,
Kohno, N.,
Kashiwabara, S.,
and Baba, T.
(1998)
Zygote
6,
311-319[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Yamagata, K.,
Honda, A.,
Kashiwabara, S.,
and Baba, T.
(1999)
Dev. Genet.
25,
115-122[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Kohno, N.,
Yamagata, K.,
Yamada, S.,
Kashiwabara, S.,
Sakai, Y.,
and Baba, T.
(1998)
Biochem. Biophys. Res. Commun.
245,
658-665[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Ohmura, K.,
Kohno, N.,
Kobayashi, Y.,
Yamagata, K.,
Sato, S.,
Kashiwabara, S.,
and Baba, T.
(1999)
J. Biol. Chem.
274,
29426-29432[Abstract/Free Full Text]
|
| 18.
|
Scarman, A. L.,
Hooper, J. D.,
Boucaut, K. J.,
Sit, M. L.,
Webb, G. C.,
Normyle, J. F.,
and Antalis, T. M.
(2001)
Eur. J. Biochem.
268,
1250-1258[Medline]
[Order article via Infotrieve]
|
| 19.
|
Inoue, M.,
Isobe, M.,
Itoyama, T.,
and Kido, H.
(1999)
Biochem. Biophys. Res. Commun.
266,
564-568[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Tanii, I.,
Araki, K.,
and Toshimori, K.
(1994)
Cell Tissue Res.
277,
61-67[Medline]
[Order article via Infotrieve]
|
| 21.
|
Toshimori, K.,
Tanii, I.,
and Araki, S.
(1995)
Mol. Reprod. Dev.
42,
72-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Johnson, L. R.,
Foster, J. A.,
Haig-Ladewig, L.,
VanScoy, H.,
Rubin, C. S.,
Moss, S. B.,
and Gerton, G. L.
(1997)
Dev. Biol.
192,
340-350[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Baba, T.,
Niida, Y.,
Michikawa, Y.,
Kashiwabara, S.,
Kodaira, K.,
Takenaka, M.,
Kohno, N.,
Gerton, G. L.,
and Arai, Y.
(1994)
J. Biol. Chem.
269,
10133-10140[Abstract/Free Full Text]
|
| 24.
|
Kashiwabara, S.,
Zhuang, T.,
Yamagata, K.,
Noguchi, J.,
Fukamizu, A.,
and Baba, T.
(2000)
Dev. Biol.
228,
106-115[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Walensky, L. D.,
and Snyder, S. H.
(1995)
J. Cell Biol.
130,
857-869[Abstract/Free Full Text]
|
| 26.
|
Rodgers, W.,
and Rose, J. K.
(1996)
J. Cell Biol.
135,
1515-1523[Abstract/Free Full Text]
|
| 27.
|
Niwa, H.,
Yamamura, K.,
and Miyazaki, J.
(1991)
Gene (Amst.)
108,
193-199[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Fuller, S. A.,
Takahashi, M.,
and Hurrell, F. G. R.
(1991)
in
Current Protocols in Molecular Biology
(Ausubel, F. M.
, Brent, P.
, Kingston, R. E.
, Moore, D. D.
, Seidman, J. G.
, Smith, J. A.
, and Struhi, K., eds)
, pp. 11.11.1-11.11.5, Greene Publishing and Wiley-Interscience, New York
|
| 29.
|
Hooper, J. D.,
Nicol, D. L.,
Dickinson, J. L.,
Eyre, H. J.,
Scarman, A. L.,
Normyle, J. F.,
Stuttgen, M. A.,
Douglas, M. L.,
Loveland, K. A.,
Sutherland, G. R.,
and Antalis, T. M.
(1999)
Cancer Res.
59,
3199-3205[Abstract/Free Full Text]
|
| 30.
|
Davie, E. W.,
Fujikawa, K.,
Kurachi, K.,
and Kisiel, W.
(1979)
Adv. Enzymol.
48,
277-318
|
| 31.
|
Perona, J. J.,
and Craik, C. S.
(1995)
Protein Sci.
4,
337-360[Abstract]
|
| 32.
|
Simons, K.,
and Ikonen, E.
(1997)
Nature
387,
569-572[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Varma, R.,
and Mayor, S.
(1998)
Nature
394,
798-801[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Harder, T.,
and Simons, K.
(1997)
Curr. Opin. Cell Biol.
9,
534-542[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Jacobson, K.,
and Dietrich, C.
(1999)
Trends Cell Biol.
9,
87-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Ohta, K.,
Sato, C.,
Matsuda, T.,
Toriyama, M.,
Lennarz, W. J.,
and Kitajima, K.
(1999)
Biochem. Biophys. Res. Commun.
258,
616-623[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Nishimura, H.,
Cho, C.,
Branciforte, G. R.,
Myles, D. G.,
and Primakoff, P.
(2001)
Dev. Biol.
233,
204-213[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Seaton, G. J.,
Hall, L.,
and Jones, R.
(2000)
Biol. Reprod.
62,
1667-1676[Abstract/Free Full Text]
|
| 39.
|
Roberts, W. L.,
Myher, J. J.,
Kuksis, A.,
Low, M. G.,
and Rosenberry, T. L.
(1988)
J. Biol. Chem.
263,
18766-18775[Abstract/Free Full Text]
|
| 40.
|
Guther, M. L.,
Dealmeida, M. L.,
Rosenberry, T. L.,
and Ferguson, M. A.
(1994)
Anal. Biochem.
219,
249-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Wong, G. W., Li, L.,
Madhusudhan, M. S.,
Krilis, S. A.,
Gurish, M. F.,
Rothenberg, M. E.,
Sali, A.,
and Stevens, R. L.
(2001)
J. Biol. Chem.
276,
20648-20658[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore